GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » United Therapeutics Corp (STU:UTH) » Definitions » Other Current Liabilities

United Therapeutics (STU:UTH) Other Current Liabilities : €143 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is United Therapeutics Other Current Liabilities?

United Therapeutics's other current liabilities for the quarter that ended in Mar. 2024 was €143 Mil.

United Therapeutics's quarterly other current liabilities declined from Sep. 2023 (€104 Mil) to Dec. 2023 (€98 Mil) but then increased from Dec. 2023 (€98 Mil) to Mar. 2024 (€143 Mil).

United Therapeutics's annual other current liabilities declined from Dec. 2021 (€116 Mil) to Dec. 2022 (€107 Mil) and declined from Dec. 2022 (€107 Mil) to Dec. 2023 (€98 Mil).


United Therapeutics Other Current Liabilities Historical Data

The historical data trend for United Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Other Current Liabilities Chart

United Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

United Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

United Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


United Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


United Therapeutics (STU:UTH) Business Description

Traded in Other Exchanges
Address
1040 Spring Street, Silver Spring, MD, USA, 20910
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

United Therapeutics (STU:UTH) Headlines

No Headlines